(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-0.29% ¥ 1 877.50
Live Chart Being Loaded With Signals
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas...
Stats | |
---|---|
Объем за сегодня | 3.92M |
Средний объем | 3.48M |
Рыночная капитализация | 1 274.86B |
EPS | ¥0 ( 2024-04-25 ) |
Дата следующего отчета о доходах | ( ¥16.38 ) 2024-07-26 |
Last Dividend | ¥19.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 27.55 |
ATR14 | ¥2.29 (0.12%) |
Объем Корреляция
M3, Inc. Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
M3, Inc. Корреляция - Валюта/Сырье
M3, Inc. Финансовые показатели
Annual | 2023 |
Выручка: | ¥238.88B |
Валовая прибыль: | ¥140.53B (58.83 %) |
EPS: | ¥66.68 |
FY | 2023 |
Выручка: | ¥238.88B |
Валовая прибыль: | ¥140.53B (58.83 %) |
EPS: | ¥66.68 |
FY | 2022 |
Выручка: | ¥230.82B |
Валовая прибыль: | ¥135.19B (58.57 %) |
EPS: | ¥72.22 |
FY | 2022 |
Выручка: | ¥208.16B |
Валовая прибыль: | ¥123.27B (59.22 %) |
EPS: | ¥94.06 |
Financial Reports:
No articles found.
M3, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥19.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥1.250 | 2008-03-26 |
Last Dividend | ¥19.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 16 | -- |
Total Paid Out | ¥91.92 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.66 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.14 | |
Div. Directional Score | 10.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9010.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
8584.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7908.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7065.T | Ex Dividend Junior | 2023-08-30 | Annually | 0 | 0.00% | |
6373.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
5301.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4350.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3526.T | Ex Dividend Junior | 2024-03-28 | Sporadic | 0 | 0.00% | |
2753.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
9639.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.190 | 1.500 | 6.21 | 9.31 | [0 - 0.5] |
returnOnAssetsTTM | 0.0922 | 1.200 | 6.93 | 8.31 | [0 - 0.3] |
returnOnEquityTTM | 0.135 | 1.500 | 9.61 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.285 | -1.000 | 7.15 | -7.15 | [0 - 1] |
currentRatioTTM | 3.58 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.00 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.23 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0377 | -1.500 | 9.37 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 98.37 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 85.88 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 74.72 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0526 | -1.500 | 9.79 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.588 | 1.000 | 3.53 | 3.53 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.286 | 1.000 | 6.28 | 6.28 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.15 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.487 | 0.800 | -0.0884 | -0.0707 | [0.5 - 2] |
Total Score | 12.95 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 28.16 | 1.000 | 7.26 | 0 | [1 - 100] |
returnOnEquityTTM | 0.135 | 2.50 | 9.75 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 74.72 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.119 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 85.88 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.285 | 1.500 | 7.15 | -7.15 | [0 - 1] |
pegRatioTTM | 1.228 | 1.500 | 5.15 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.244 | 1.000 | 6.40 | 0 | [0.1 - 0.5] |
Total Score | 7.14 |
M3, Inc.
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа